Form 4 for AORT ARTIVION, INC.
Accepted 2024-03-21 00:00:00 ET · period of report 2024-03-20 · accession 0000784199-24-000164 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-21 | 2024-03-20 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $20.39 | -2,183 | 83.3K | -3% | -$44.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-20 | S | D | 2,183 | $20.39 | 83,296 | D | — | — | (F1) These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. |